Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (H (Q41779635)
Jump to navigation
Jump to search
scientific article published on 17 April 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (H |
scientific article published on 17 April 2009 |
Statements
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC) (English)
Wai-Man Lam
Tin-Lun Lam
Hiu-Chi Chong
Pui-Kin So
Sui-Yi Kwok
Simon Arnold
Paul Ning-Man Cheng
Denys N Wheatley
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference